Associate Professor, Department of Pharmacology, Alluri Sitarama Raju Academy of Medical Sciences, Eluru-534005, West Godavari District, Andhra Pradesh, India
*Correspondence author: Dr. Balu Jatthavath, Associate Professor, Department of Pharmacology Alluri Sitarama Raju Academy of Medical Sciences, Eluru-534005, West Godavari District, Andhra Pradesh, India E-mal ID: drjatthavath@gmail.com
Online published on 13 June, 2016.
Diabetes mellitus is the chronic disorder emerging as a major world health problem which increases the rate of morbidity and mortality.
was to ascertain patterns of prescription of oral hypoglycemic agents to type 2 diabetic patients attending a tertiary care hospital A prospective study was conducted in 150 established diabetes mellitus type 2 patients attending outpatient department of a tertiary care hospital of AP. The prescriptions were reviewed and the patients were interviewed.
Out of 150 patients, more than half were males (n = 79, 52.5%). The mean age of the patients were found to be 52.2 ± 12.1 years. A total of 238 oral hypoglycemic agents were prescribed to the patients. A significant number of patients were prescribed combination therapy (n = 88, 58.5%) as compared to monotherapy (n = 62, 41.3%), p < 0.05.
Biguanides were the most commonly prescribed class of oral hypoglycemic agents, followed by sulphonylureas, thiazolidinediones and alpha-glucosidase inhibitors.
Oral Hypoglycemic Agent, Diabetes Mellitus Type 2, Prescribing Pattern
